Stock PBIO PRESSURE BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pressure BioSciences, Inc.

Equities

PBIO

US74112E2081

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets
Other stock markets
 10:21:41 2024-04-26 am EDT 		5-day change 1st Jan Change
0.2268 USD +3.09% Intraday chart for Pressure BioSciences, Inc. -11.41% -31.27%
Feb. 15 Pressure BioSciences, Inc. Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing CI
Feb. 05 Transcript : CBH International LLC, Pressure BioSciences, Inc. - M&A Call

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 4.569 3.942 3 8.309 18.35 15.89
Enterprise Value (EV) 1 17.66 8.843 10.93 17.89 32.86 36.41
P/E ratio -0.36 x -0.15 x -0.16 x -0.4 x -0.68 x -0.81 x
Yield - - - - - -
Capitalization / Revenue 2.04 x 1.6 x 1.66 x 6.81 x 9.17 x 9.19 x
EV / Revenue 7.88 x 3.6 x 6.04 x 14.7 x 16.4 x 21.1 x
EV / EBITDA -3.81 x -2.02 x -1.92 x -4.01 x -8.06 x -7.62 x
EV / FCF -2.49 x -1.8 x -4.29 x -5.03 x -3.13 x -7.97 x
FCF Yield -40.1% -55.6% -23.3% -19.9% -32% -12.6%
Price to Book -0.32 x -0.62 x -0.26 x -0.52 x -0.95 x -0.54 x
Nbr of stocks (in thousands) 1,305 1,752 2,400 3,919 7,945 12,221
Reference price 2 3.500 2.250 1.250 2.120 2.310 1.300
Announcement Date 4/2/18 4/16/19 4/14/20 4/15/21 4/5/22 4/12/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 2.24 2.458 1.81 1.221 2.002 1.729
EBITDA 1 -4.638 -4.383 -5.682 -4.458 -4.075 -4.779
EBIT 1 -4.647 -4.477 -5.806 -4.586 -4.185 -4.898
Operating Margin -207.41% -182.15% -320.75% -375.7% -209.01% -283.25%
Earnings before Tax (EBT) 1 -10.72 -9.699 -11.88 -16.01 -20.15 -16.08
Net income 1 -10.72 -9.699 -11.66 -16.01 -20.15 -16.08
Net margin -478.27% -394.62% -644.25% -1,311.29% -1,006.48% -929.64%
EPS 2 -9.617 -15.33 -7.984 -5.322 -3.418 -1.610
Free Cash Flow 1 -7.085 -4.916 -2.547 -3.559 -10.51 -4.57
FCF margin -316.23% -200.02% -140.74% -291.57% -524.7% -264.28%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/2/18 4/16/19 4/14/20 4/15/21 4/5/22 4/12/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 13.1 4.9 7.93 9.58 14.5 20.5
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -2.821 x -1.118 x -1.395 x -2.148 x -3.561 x -4.295 x
Free Cash Flow 1 -7.09 -4.92 -2.55 -3.56 -10.5 -4.57
ROE (net income / shareholders' equity) 93.2% 93.5% 128% 110% 103% 58.6%
ROA (Net income/ Total Assets) -153% -123% -172% -139% -102% -126%
Assets 1 6.984 7.903 6.774 11.5 19.78 12.71
Book Value Per Share 2 -10.90 -3.640 -4.730 -4.060 -2.440 -2.390
Cash Flow per Share 2 0.0600 0.0600 0.0100 0 0.0100 0
Capex 1 0.02 - 0.02 0 0.12 0.02
Capex / Sales 0.97% - 1.29% 0.14% 6.14% 1.2%
Announcement Date 4/2/18 4/16/19 4/14/20 4/15/21 4/5/22 4/12/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
PRESSURE BIOSCIENCES, INC. Stock Pressure BioSciences, Inc.
-31.27% 7.63M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. PBIO Stock
  4. Financials Pressure BioSciences, Inc.